Navin Thadani

Currently, Senior Vice President of Business Development at Aurobindo Pharma Europe. Aurobindo Pharma is the leading Indian generic pharmaceutical company in Europe, with European sales of over 750m Euros. We are present in 9 European countries that account for 75% of the European pharma market value. Countries of our current presence cover a range of business models from pure brands, quasi brands, and pure generics; and on the other axis include retail, hospital, and OTC markets. I am responsible for business development for this diverse range of markets. Over 20 years of experience working at enterprising companies in their growth phase. Expertise covers acquisitions of companies, acquisitions of portfolios of branded products and unbranded products, integration of acquisitions, market expansion, and a variety of partnerships including in-licensing, co-development, and contract development. Company acquisitions and product acquisitions have involved several countries across Europe. Product deals have covered brands, niche generics, and complex generics. End to end deal making from opportunity identification, investment due diligence, contractual negotiations, deal closure, and execution/integration. Obtained the approval from the European Commission for the acquisitions where necessary. Built and managed relationships with various stakeholders involved within the industry and within the company. Built an effective team that was able to deliver the above.